Research Article
Glycoprotein IIb/IIIa Inhibitors Use and Outcome after Percutaneous Coronary Intervention for Non-ST Elevation Myocardial Infarction
Table 2
Procedural characteristics.
| | No GP IIb/IIIa inhibitor used () | GP IIb/IIIa inhibitor used () | Significance () |
| Access route | | | | Radial | 691 (39.4%) | 383 (29.6%) | <0.001* | Brachial | 1 (0.06%) | 2 (0.15%) | 0.267 | Femoral | 1061 (60.5%) | 909 (70.2%) | <0.001* | Target vessel(s) | | | | Right coronary artery | 633 (36.1%) | 499 (38.6%) | 0.172 | Left main coronary artery | 36 (2.05%) | 38 (2.93%) | 0.123 | Left anterior descending artery | 662 (37.8%) | 690 (53.3%) | <0.001* | Left circumflex artery | 496 (28.3%) | 386 (38.3%) | 0.374 | Bypass graft | 94 (5.36%) | 68 (5.26%) | 0.935 | Multivessel disease | 401 (22.9%) | 312 (24.1%) | 0.436 | Multivessel intervention | 347 (19.8%) | 401 (31.0%) | <0.001* | Drug-eluting stent used | 909 (51.9%) | 757 (58.5%) | <0.001* | IVUS used | 86 (4.91%) | 56 (4.23%) | 0.487 | Pressure wire used | 88 (5.02%) | 14 (1.08%) | <0.001* | Success | 1697 (96.8%) | 1286 (99.4%) | <0.001* |
|
|
value < 0.05.
|